Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Apr:28:262-303.
doi: 10.1016/j.jtos.2023.04.008. Epub 2023 Apr 11.

TFOS Lifestyle: Impact of lifestyle challenges on the ocular surface

Affiliations
Meta-Analysis

TFOS Lifestyle: Impact of lifestyle challenges on the ocular surface

Anat Galor et al. Ocul Surf. 2023 Apr.

Erratum in

Abstract

Many factors in the domains of mental, physical, and social health have been associated with various ocular surface diseases, with most of the focus centered on aspects of dry eye disease (DED). Regarding mental health factors, several cross-sectional studies have noted associations between depression and anxiety, and medications used to treat these disorders, and DED symptoms. Sleep disorders (both involving quality and quantity of sleep) have also been associated with DED symptoms. Under the domain of physical health, several factors have been linked to meibomian gland abnormalities, including obesity and face mask wear. Cross-sectional studies have also linked chronic pain conditions, specifically migraine, chronic pain syndrome and fibromyalgia, to DED, principally focusing on DED symptoms. A systematic review and meta-analysis reviewed available data and concluded that various chronic pain conditions increased the risk of DED (variably defined), with odds ratios ranging from 1.60 to 2.16. However, heterogeneity was noted, highlighting the need for additional studies examining the impact of chronic pain on DED signs and subtype (evaporative versus aqueous deficient). With respect to societal factors, tobacco use has been most closely linked to tear instability, cocaine to decreased corneal sensitivity, and alcohol to tear film disturbances and DED symptoms.

Keywords: Anxiety; Chronic pain; Depression; Dry eye disease; Mental health; Ocular surface disease; Physical factors; Sleep disorders; Social factors; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Anat Galor: Novartis (C), Novaliq (C), Oyster Point Pharma (C), Palatin Technologies (C), Oculis (C), Dompé (C), Allergan (C), Shire (C) Alexis Ceecee Britten-Jones: Plano (R) Yun Feng: None. Giulio Ferrari: Bausch + Lomb (F) David Goldblum: Roche (F), Novartis (P), Haag-Streit (C), Johnson & Johnson Vision (C) Preeya K. Gupta: Alcon (C), Allergan (C), Aldeyra (C), Azura (C), Expert Opinion (C), HanAll Biopharma (C), Johnson & Johnson Vision (C), Kala (C), New World Medical (C), Novartis (C), Ocular Science (C), Ocular Therapeutix (C), Orasis (C), Oyster Point Pharma (C), Santen (C), Spyglass (C), , Sight Sciences (C), Surface Ophthalmics (C), Sun Pharmaceuticals (C), Tarsus (C), Tear Lab (C), Tear Clear (C), Tissue Tech (C), Visionology (C), Zeiss (C) Jesus Merayo-Lloves: BTI + d(C), Brill(C), Faes Pharma, Sophia(C), Théa (C) Kyung-Sun Na: None. Shehzad A. Naroo: None. Kelly K. Nichols: Azura (F), Tear Science (F), Oyster Point Pharma (I,C), Bausch + Lomb (C), Bruder (C), Dompé (C), HanAll Bio (C), Kala (F,C), Novartis/Shire/Takeda (C), Osmotica (F), Sight Sciences (F), Tear Film Innovations/Alcon/Acquiom (C), Thea (C), Tarsus (C), TopiVert (C), Trukera (C), Versea (C), Xequel (C), Nicox (C), Novaliq (C) Eduardo M. Rocha: Christalia Lab ( Louis Tong: Azura (C), Allergan (C), Santen (C), Alcon/Novartis (F,R), Bausch + Lomb (R), Vivavision Biotech (C) Michael T. M. Wang: None. Jennifer P. Craig: Adelphi Values Ltd (R), Alcon (F,R,C), Asta Supreme (R), Azura Ophthalmics (F,R), E-Swin (F,R), Johnson & Johnson Vision (R), Manuka Health (F), Medmont International (R), Novoxel (R), Oculeve (F), Photon Therapeutics (R), Resono Ophthalmic (F,R), TFOS (S), Th'ea Laboratories (F,R), Topcon (F,R), TRG Natural Pharmaceuticals (F,R).

Publication types

LinkOut - more resources